Opiant Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11, 2021

Rhea-AI Summary

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will release its financial results for Q1 2021 on May 11, 2021, after market close. A conference call will follow at 4:30 PM ET the same day. Investors can join by dialing 877-407-0792 (U.S.) or 201-689-8263 (International) with the conference ID 13718590. The webcast will be available on the company's investor website.

Opiant is known for developing NARCAN® Nasal Spray and is focusing on creating new treatments for drug overdose and addiction.

Positive

• Scheduled Q1 2021 financial results announcement may provide investors insight into company performance.
• Company developing treatments for addictions and drug overdose, indicating potential growth in a critical healthcare sector.

Negative

• None.

SANTA MONICA, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the first quarter ended March 31, 2021, after the financial markets close on Tuesday, May 11, 2021.  

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Tuesday May 11, 2021. To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13718590. To access the live webcast, please go to the investors section of Opiant’s website at http://ir.opiant.com/.   Following the live webcast, an archived version of the call will be available on the website.

Tuesday May 11 @ 4:30 pm ET
Domestic:	877-407-0792
International:	201-689-8263
Conference ID:	13718590
Webcast:	http://ir.opiant.com/

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
For more information visit: www.opiant.com.

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com 

 

FAQ

When will Opiant Pharmaceuticals report its Q1 2021 financial results?

Opiant Pharmaceuticals will report its Q1 2021 financial results on May 11, 2021, after market close.

What time is the conference call for Opiant's Q1 results?

The conference call for Opiant's Q1 results is scheduled for May 11, 2021, at 4:30 PM ET.

How can I access the conference call for Opiant Pharmaceuticals?

You can access the conference call by dialing 877-407-0792 in the U.S. or 201-689-8263 internationally, using conference ID 13718590.

Where can I find the webcast of Opiant Pharmaceuticals' conference call?

The webcast will be available on Opiant's investor website at http://ir.opiant.com/.

What is Opiant Pharmaceuticals known for?

Opiant Pharmaceuticals is known for developing NARCAN® Nasal Spray and focusing on new medicines for drug overdose and addiction.